| Literature DB >> 32144857 |
Melissa T Hooijmans1, Jithsa R C Monte2, Martijn Froeling3, Sandra van den Berg-Faay2, Vincent L Aengevaeren4,5, Robert Hemke2, Frank F Smithuis2, Thijs M H Eijsvogels4, Adrianus J Bakermans2, Mario Maas2, Aart J Nederveen2, Gustav J Strijkers1.
Abstract
BACKGROUND: The majority of sports-related injuries involve skeletal muscle. Unlike acute trauma, which is often caused by a single traumatic event leading to acute symptoms, exercise-induced microtrauma may remain subclinical and difficult to detect. Therefore, novel methods to detect and localize subclinical exercise-induced muscle microtrauma are desirable.Entities:
Keywords: DTI; inflammation; microstructure; muscle injury; perfusion
Mesh:
Year: 2020 PMID: 32144857 PMCID: PMC7496541 DOI: 10.1002/jmri.27106
Source DB: PubMed Journal: J Magn Reson Imaging ISSN: 1053-1807 Impact factor: 4.813
Scan Parameters for qT2, DWI, Dixon, and Fat‐Suppressed T2‐Weighted Sequences
| qT2 | DWI | Noise map | Dixon | T2w‐SPIR | |
|---|---|---|---|---|---|
| Sequence | MSE | SE‐EPI | SE‐EPI | MS_FFE | MS_TSE |
| Matrix size | 160 × 160 | 160 × 160 | 160 × 160 | 320 × 320 | 640 × 640 |
| Voxel size (mm3) | 3 × 3 × 6 | 3 × 3 × 6 | 3 × 3 × 6 | 1.5 × 1.5 × 6 | 0.75 × 0.75 × 3 |
| Slice gap (mm) | 6 | — | — | — | — |
| Slices | 17 | 31 | 31 | 31 | 31 |
| TR (msec) | 5633 | 5000 | 210 | 5500 | |
| TE (msec) | 17*7.6 | 57 | 57 | 2.6/3.36/4.12/4.88 | 70 |
| Flip angle | 90/180° | 90/180° | 90/180° | 8° | 90° |
| b‐value (s/mm2) (# gradient orientations) | — | 0(1), 1(6), 10(3), 25(3), 100(3), 200(6), 400(8), 600(12) | 0(1), 400(1) | — | — |
| Fat suppression | SPAIR/SPIR/SSGR | SPAIR/SPIR/SSGR | SPIR | ||
| SENSE | 2 | 1.9 | 1.9 | 2 | 2 |
SENSE: sensitivity encoding.
Figure 1Study design. (a) Timeline indicating marathon and timepoints of MRI and blood sampling. (b) Schematic view of the scan geometry with three stacks of 31 slices and 30 mm section overlap covering the upper legs. Bottom right: Dixon images at mid‐thigh level with manually drawn ROIs for eight upper leg muscles: 1 = BFS, 2 = BFL, 3 = ST, 4 = SM, 5 = VM, 6 = VI, 7 = VL, 8 = RF.
Baseline Subject Characteristics of the 11 Marathon Finishers
| Subject characteristics | Mean ± SD |
|---|---|
| Age (years) | 51 ± 6 |
| Previous marathons ( | 13 ± 7 |
| Height (cm) | 180 ± 7 |
| BMI, kg/m2 | 23.6 ± 1.1 |
| Weight (kg) | 76.9 ± 7.2 |
| Finish time (min) | 236 ± 35 |
Figure 2Boxplots showing the CK concentrations (U/L) in the venous blood for all participants at baseline, postmarathon, and follow‐up (a) showing all participants and (b) with exclusion of participants with overt injuries. Significant differences are indicated with an asterisk (*).
Figure 3Raw and processed example images of a representative subject (47 years/male) for the three timepoints. Left column: baseline, middle column: postmarathon and right column: follow‐up. Top: water images from Dixon sequence. Middle: raw diffusion images for b = 0 s/mm2 and MD maps. Bottom: raw images from first TE of T2 sequence and processed EPG T2 maps.
Mean and Standard Deviations for the Diffusion Parameters, Per Muscle, Per Timepoint
| Muscle | Timepoint | λ1 (mm2/sec) | λ2 (mm2 /sec) | λ3 (mm2 /sec) | MD (mm2 /sec) | FA(‐) | RD (mm2 /sec) | Perfusion fraction (%) | Water T2 values (msec) |
|---|---|---|---|---|---|---|---|---|---|
| Hamstrings | |||||||||
| BFS |
| 1.96 ± 0.09 | 1.47 ± 0.09 | 1.26 ± 0.05 | 1.56 ± 0.06 | 0.23 ± 0.03 | 1.36 ± 0.07 | 0.042 ± 0.02 | 30.6 ± 1.2 |
|
| 1.96 ± 0.13 | 1.43 ± 0.1 | 1.25 ± 0.1 | 1.55 ± 0.1 | 0.23 ± 0.02 | 1.34 ± 0.1 | 0.043 ± 0.01 | 30.7 ± 1.1 | |
|
| 1.93 ± 0.14 | 1.42 ± 0.09 | 1.25 ± 0.08 | 1.54 ± 0.08 | 0.23 ± 0.03 | 1.33 ± 0.08 | 0.037 ± 0.02 | 30.2 ± 1.2 | |
| BFL |
| 1.97 ± 0.08 | 1.54 ± 0.05 | 1.33 ± 0.05 | 1.62 ± 0.05 | 0.20 ± 0.03 | 1.44 ± 0.04 | 0.03 ± 0.01 | 30.2 ± 1.1 |
|
| 1.99 ± 0.07 | 1.56 ± 0.05 | 1.37 ± 0.06 #* | 1.64 ± 0.04 #* | 0.19 ± 0.02 | 1.47 ± 0.04 #* | 0.024 ± 0.004 | 30.05 ± 0.8 | |
|
| 1.95 ± 0.07 | 1.52 ± 0.04 | 1.35 ± 0.05 | 1.61 ± 0.04 | 0.19 ± 0.03 | 1.43 ± 0.04 | 0.024 ± 0.01 | 29.8 ± 0.8 | |
| ST |
| 1.99 ± 0.06 | 1.50 ± 0.06 | 1.41 ± 0.05 | 1.62 ± 0.05 | 0.21 ± 0.02 | 1.43 ± 0.05 | 0.03 ± 0.01 | 29.1 ± 1.1 |
|
| 2.04 ± 0.06 | 1.54 ± 0.05 | 1.37 ± 0.04 #* | 1.66 ± 0.05 #* | 0.20 ± 0.01 | 1.47 ± 0.05#* | 0.03 ± 0.01 | 29.1 ± 1.3 | |
|
| 1.99 ± 0.07 | 1.50 ± 0.05 | 1.36 ± 0.05 | 1.63 ± 0.04 | 0.20 ± 0.02 | 1.44 ± 0.05 | 0.03 ± 0.01 | 28.7 ± 0.9 | |
| SM |
| 1.86 ± 0.06 | 1.48 ± 0.06 | 1.31 ± 0.04 | 1.55 ± 0.05 | 0.18 ± 0.02 | 1.40 ± 0.05 | 0.039 ± 0.01 | 30.1 ± 1.1 |
|
| 1.87 ± 0.05 | 1.48 ± 0.06 | 1.33 ± 0.05 | 1.56 ± 0.05 | 0.19 ± 0.02 | 1.41 ± 0.06 | 0.036 ± 0.01 | 30.0 ± 1.0 | |
|
| 1.85 ± 0.07 | 1.48 ± 0.08 | 1.32 ± 0.06 | 1.55 ± 0.06 | 0.18 ± 0.01 | 1.40 ± 0.07 | 0.032 ± 0.01 | 29.9 ± 1.3 | |
| Quadriceps | |||||||||
| VM |
| 1.82 ± 0.04 | 1.44 ± 0.05 | 1.29 ± 0.05 | 1.52 ± 0.04 | 0.18 ± 0.02 | 1.37 ± 0.04 | 0.04 ± 0.01 | 30.5 ± 0.9 |
|
| 1.84 ± 0.04 | 1.48 ± 0.05 | 1.35 ± 0.04 #* | 1.56 ± 0.03 #* | 0.16 ± 0.02 | 1.41 ± 0.04#* | 0.04 ± 0.004 | 30.4 ± 0.9 | |
|
| 1.81 ± 0.06 | 1.46 ± 0.04 | 1.32 ± 0.05 | 1.54 ± 0.04 | 0.17 ± 0.02 | 1.39 ± 0.05 | 0.03 ± 0.01 | 30.4 ± 0.7 | |
| VL |
| 1.94 ± 0.05 | 1.56 ± 0.06 | 1.39 ± 0.05 | 1.63 ± 0.05 | 0.17 ± 0.01 | 1.48 ± 0.05 | 0.04 ± 0.01 | 30.4 ± 0.9 |
|
| 1.96 ± 0.03 | 1.59 ± 0.04 | 1.43 ± 0.04 #* | 1.65 ± 0.03 #* | 0.16 ± 0.01 | 1.51 ± 0.04 #* | 0.03 ± 0.01 | 30.4 ± 0.9 | |
|
| 1.93 ± 0.03 | 1.56 ± 0.05 | 1.39 ± 0.05 | 1.63 ± 0.04 | 0.17 ± 0.02 | 1.47 ± 0.05 | 0.04 ± 0.01 | 30.3 ± 0.6 | |
| VI |
| 1.92 ± 0.05 | 1.57 ± 0.05 | 1.38 ± 0.05 | 1.63 ± 0.05 | 0.17 ± 0.02 | 1.48 ± 0.05 | 0.03 ± 0.01 | 30.1 ± 0.8 |
|
| 1.94 ± 0.03 | 1.59 ± 0.04 | 1.43 ± 0.05 #* | 1.65 ± 0.03 #* | 0.16 ± 0.02 | 1.51 ± 0.04 #* | 0.03 ± 0.01 | 30.3 ± 0.9 | |
|
| 1.91 ± 0.05 | 1.56 ± 0.04 | 1.38 ± 0.05 | 1.62 ± 0.04 | 0.17 ± 0.02 | 1.47 ± 0.04 | 0.03 ± 0.01 | 29.9 ± 0.7 | |
| RF |
| 1.83 ± 0.1 | 1.42 ± 0.1 | 1.23 ± 0.09 | 1.50 ± 0.02 | 0.20 ± 0.02 | 1.33 ± 0.09 | 0.04 ± 0.02 | 29.1 ± 0.9 |
|
| 1.84 ± 0.1 | 1.46 ± 0.08 | 1.28 ± 0.09 | 1.53 ± 0.09 | 0.19 ± 0.02 | 1.37 ± 0.09 | 0.04 ± 0.01 | 29.0 ± 11 | |
|
| 1.84 ± 0.3 | 1.39 ± 0.15 | 1.19 ± 0.2 | 1.47 ± 0.16 | 0.22 ± 0.09 | 1.29 ± 0.16 | 0.04 ± 0.02 | 29.1 ± 0.8 | |
BFS: Biceps Femoris Short Head, BFL: Biceps Femoris Long Head, ST: Semitendinosus, SM: Semimembranosus, VM: Vastus Medialis, VL: Vastus Lateralis, VI: Vastus Intermedius and RF: Rectus Femoris. λ1: First eigenvalue, λ2: Second eigenvalue, λ3 Third eigenvalue. MD: Mean Diffusivity, FA: Fractional Anisotropy, RD: Radial Diffusivity. Differences between baseline and postmarathon are indicated with an asterisk (*). Differences between postmarathon and follow‐up are indicated with a number sign (#).
Figure 4Time courses of FA, MD, λ3, qT2, and perfusion fraction for all upper leg muscles separately (left and right leg taken together; left column) and for all subjects separately for the BFL and VM muscle. Each muscle (left column) or subject (middle and right column) is shown in gray, while the mean and standard deviation are shown in black. Asterisks indicate an overall time‐effect in the left column and a significant change between timepoints in the middle and right column. The timepoints are defined as 0 = baseline, 1 = postmarathon, and 2 = follow‐up.
Mean and Standard Deviations for the Mean Diffusivity and qT2, for the Five Segments of BFL and VM Muscle, Per Timepoint
| Muscle | Parameter | Timepoint | Segment 1 | Segment 2 | Segment 3 | Segment 4 | Segment 5 |
|---|---|---|---|---|---|---|---|
| BFL | MD | B | 1.51 ± 0.09 | 1.57 ± 0.04 | 1.62 ± 0.04 | 1.63 ± 0.04 | 1.57 ± 0.06 |
| Post | 1.55 ± 0.08 | 1.62 ± 0.04* | 1.65 ± 0.04 | 1.65 ± 0.04 | 1.61 ± 0.04 | ||
| 2‐week | 1.50 ± 0.09 | 1.55 ± 0.07 | 1.61 ± 0.04 | 1.62 ± 0.02 | 1.57 ± 0.04 | ||
| qT2 | B | 30.6 ± 1.6 | 29.9 ± 1.25 | 29.7 ± 1.25 | 29.6 ± 1.4 | 29.3 ± 1.3 | |
| Post | 31.8 ± 1.6* | 30.6 ± 0.9 | 29.9 ± 0.9 | 29.2 ± 1.2 | 29.6 ± 1.1 | ||
| 2‐week | 31.8 ± 1.9 | 30.0 ± 1.2 | 29.5 ± 1.1 | 29.4 ± 0.9 | 29.2 ± 1 | ||
| VM | MD | B | 1.44 ± 0.05 | 1.48 ± 0.04 | 1.52 ± 0.05 | 1.59 ± 0.05 | 1.60 ± 0.05 |
| Post | 1.51 ± 0.04* | 1.53 ± 0.05* | 1.54 ± 0.06 | 1.60 ± 0.04 | 1.60 ± 0.03 | ||
| 2‐week | 1.50 ± 0.08 | 1.53 ± 0.06 | 1.53 ± 0.07 | 1.56 ± 0.05 | 1.58 ± 0.04 | ||
| qT2 | B | 30.6 ± 1.55 | 30.5 ± 1.3 | 29.9 ± 1.1 | 29.8 ± 0.8 | 29.8 ± 1.0 | |
| Post | 31.1 ± 1.7 | 31.03 ± 1.3 | 30.3 ± 1.04 | 30.3 ± 1.11 | 30.1 ± 1.0 | ||
| 2‐week | 30.9 ± 1 | 30.9 ± 0.8 | 30.2 ± 0.8 | 30.1 ± 0.6 | 30.1 ± 0.7 |
BFL: Biceps Femoris Long Head, VM: Vastus Medialis, MD: Mean Diffusivity, qT2: quantitative T2 measurements, B: baseline, post: postmarathon, 2‐week: follow‐up. Differences between baseline and postmarathon are indicated with an asterisk (*).
Figure 5Comparisons between whole muscle volume and local measurements. Left: boxplots showing MD and qT2 for the BFL (top) and VM (bottom) muscle for all subjects based on a whole volume assessment. Middle: line graphs of MD and qT2 for five segments of the BFL and VM muscle averaged over all subjects at baseline (black), postmarathon (red), and follow‐up (gray). Asterisks indicate significant time‐effects between baseline and postmarathon. Right: showing the location of the five muscle segments for the BFL and VM muscle. Note that the difference in MD and qT2 values between timepoints is more pronounced for the localized measurements, indicating the higher sensitivity to detect changes.